These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33689318)

  • 41. Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.
    Anh NT; Cam PD; Dalsgaard A
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):856-62. PubMed ID: 12041563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnitude of drug resistant Shigellosis: a report from Bangalore.
    Srinivasa H; Baijayanti M; Raksha Y
    Indian J Med Microbiol; 2009; 27(4):358-60. PubMed ID: 19736408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Update on: Shigella new serogroups/serotypes and their antimicrobial resistance.
    Muthuirulandi Sethuvel DP; Devanga Ragupathi NK; Anandan S; Veeraraghavan B
    Lett Appl Microbiol; 2017 Jan; 64(1):8-18. PubMed ID: 27783408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Evaluation of High Fluoroquinolone Resistant Genes in Endemic Cases of Shigellosis, Northeast Part of Karnataka, India.
    C P; Desai P; R KC
    Ann Glob Health; 2016; 82(5):832-839. PubMed ID: 28283137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial resistance and genetic characterization of Shigella spp. in Shanxi Province, China, during 2006-2016.
    Wang Y; Ma Q; Hao R; Zhang Q; Yao S; Han J; Ren B; Fan T; Chen L; Xu X; Qiu S; Yang H
    BMC Microbiol; 2019 May; 19(1):116. PubMed ID: 31142259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of drug-resistant Shigella infections.
    Klontz KC; Singh N
    Expert Rev Anti Infect Ther; 2015 Jan; 13(1):69-80. PubMed ID: 25399653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Invasive shigellosis in MSM.
    Serafino Wani RL; Filson SA; Chattaway MA; Godbole G
    Int J STD AIDS; 2016 Sep; 27(10):917-9. PubMed ID: 26429891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of whole-genome sequencing to identify clusters of
    Mitchell HD; Mikhail AFW; Painset A; Dallman TJ; Jenkins C; Thomson NR; Field N; Hughes G
    Microb Genom; 2019 Nov; 5(11):. PubMed ID: 31682221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanonized tetracycline cures deadly diarrheal disease 'shigellosis' in mice, caused by multidrug-resistant Shigella flexneri 2a bacterial infection.
    Mukherjee R; Dutta D; Patra M; Chatterjee B; Basu T
    Nanomedicine; 2019 Jun; 18():402-413. PubMed ID: 30448527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
    Iwalokun BA; Gbenle GO; Smith SI; Ogunledun A; Akinsinde KA; Omonigbehin EA
    J Health Popul Nutr; 2001 Sep; 19(3):183-90. PubMed ID: 11761772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Death from multi-resistant shigelloses: a case study from Fiji.
    Watson C
    Pac Health Dialog; 2006 Sep; 13(2):111-4. PubMed ID: 18181399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Community-based evaluation of the effect of breast-feeding on the risk of microbiologically confirmed or clinically presumptive shigellosis in Bangladeshi children.
    Ahmed F; Clemens JD; Rao MR; Sack DA; Khan MR; Haque E
    Pediatrics; 1992 Sep; 90(3):406-11. PubMed ID: 1518697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial-resistance pattern of Shigella species in children: a six-year study in an Iranian referral Hospital.
    Mamishi S; Arab Yazdi Z; Mahmoudi S; Moradzadeh M; Taghi Haghi Ashtiani M; Pourakbari B
    Ann Ig; 2019; 31(4):356-364. PubMed ID: 31268120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993.
    Lima AA; Lima NL; Pinho MC; Barros Juñior EA; Teixeira MJ; Martins MC; Guerrant RL
    Antimicrob Agents Chemother; 1995 Jan; 39(1):256-9. PubMed ID: 7695319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotics in the management of shigellosis in children: what role for the quinolones?
    Fontaine O
    Rev Infect Dis; 1989; 11 Suppl 5():S1145-50. PubMed ID: 2672246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiological, clinical and microbiological features of shigellosis among hospitalized children in northern Israel.
    Admoni O; Yagupsky P; Golan A; Kenes Y; Schifroni G; Horowitz I
    Scand J Infect Dis; 1995; 27(2):139-44. PubMed ID: 7660077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shigella antibiotic resistance in central Turkey: comparison of the years 1987-1994 and 1995-2002.
    Ozmert EN; Göktürk B; Yurdakök K; Yalçin SS; Gür D
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):359-62. PubMed ID: 15735493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ceftriaxone resistant Shigella flexneri, an emerging problem.
    Gupta S; Mishra B; Muralidharan S; Srinivasa H
    Indian J Med Sci; 2010 Dec; 64(12):553-6. PubMed ID: 21258157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antibiotic resistance of Shigella strains isolated in Cádiz (author's transl)].
    García Martos P; Marín Casanova P; García Herruzo J; Fernández Gutiérrez del Alamo C
    Med Clin (Barc); 1980 Dec; 75(10):425-9. PubMed ID: 7464328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Comprehensive Computational Investigation into the Conserved Virulent Proteins of
    Palit P; Chowdhury FT; Baruah N; Sarkar B; Mou SN; Kamal M; Siddiqua TJ; Noor Z; Ahmed T
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.